Safety is a primary concern for NTD programmes. For example, medicines that are donated for treatment are manufactured under stringent regulatory authority guidelines or are prequalified by WHO, with considerable effort in determining safety for mass treatment and in conducting surveillance for serious adverse events. These training modules are intended to help national programmes for neglected tropical diseases (NTDs) plan, prepare and monitor the safe administration of medicines for treatment of these diseases.